Importantly, our results demonstrate that our novel cancer-susceptibility genes form coherent functional pathways with known cancer genes like TP53 and BRCA1/2, suggesting that many of these novel genes are likely to have a functional role in cancer risk. The gene discussed is TP53; the disease is cancer.